Zhenlong Ye
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 13
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 3
- Pancreatic and Hepatic Oncology Research 2
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Qijun Qian (16 shared papers)Huajun Jin (8 shared papers)Xinchun Li (4 shared papers)Xinyue Wang (4 shared papers)Liang Cheng (3 shared papers)Changzheng Zhang (1 shared paper)Shuo Ma (2 shared papers)Zhong Li (3 shared papers)
- Journals
- Journal of Cancer (5 papers)International Journal of Biological Sciences (2 papers)Acta Pharmacologica Sinica (1 paper)International Immunopharmacology (1 paper)Cancer Biology & Therapy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Zhenlong Ye
20 papers receiving 923 citations
Zhenlong Ye's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 578
- Immunology 315
- Cancer Research 137
- Genetics 150
- Molecular Biology 301
Countries citing papers authored by Zhenlong Ye
This map shows the geographic impact of Zhenlong Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenlong Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenlong Ye more than expected).
Fields of papers citing papers by Zhenlong Ye
This network shows the impact of papers produced by Zhenlong Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenlong Ye. The network helps show where Zhenlong Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenlong Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Current Progress in CAR-T Cell Therapy for Solid Tumors Hit paper breakdown → | 2019 | 372 |
| 2 | 2020 | 127 | |
| 3 | 2015 | 89 | |
| 4 | 2016 | 78 | |
| 5 | 2020 | 41 | |
| 6 | 2015 | 37 | |
| 7 | 2018 | 35 | |
| 8 | 2017 | 33 | |
| 9 | 2020 | 29 | |
| 10 | 2017 | 17 | |
| 11 | 2021 | 16 | |
| 12 | 2019 | 13 | |
| 13 | 2016 | 13 | |
| 14 | 2017 | 9 | |
| 15 | 2019 | 8 | |
| 16 | 2020 | 6 | |
| 17 | 2022 | 4 | |
| 18 | Current Progress in CAR-T Cell Therapy for Solid Tumors | 2019 | 2 |
| 19 | 2024 | 2 | |
| 20 | Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies | 2019 | 2 |
About Zhenlong Ye
Zhenlong Ye is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Cancer Research, having authored 20 papers that have together received 933 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Virus-based gene therapy research (5 papers), Nanowire Synthesis and Applications (3 papers), Cancer Genomics and Diagnostics (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Cells and Metastasis (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Oncology (578 citations), Immunology (315 citations), Cancer Research (137 citations), Genetics (150 citations) and Molecular Biology (301 citations). Zhenlong Ye has collaborated with scholars based in China and United States. Frequent co-authors include Qijun Qian, Huajun Jin, Xinchun Li, Xinyue Wang, Liang Cheng, Changzheng Zhang, Shuo Ma, Zhong Li, Zenghui Xu and Yuan Zhuang. Their work appears in journals such as Journal of Cancer, International Journal of Biological Sciences, Acta Pharmacologica Sinica, International Immunopharmacology and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.